Search Within

Jason Konner

Formats
  1. Journal Article (83)
  2. Meeting Abstract (69)
  3. Correspondence (2)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (156)
  2. GDMT, Medicine (156)
  3. Gynecologic Medicine Service (156)
  4. Gynecology Disease Management Team (156)
  5. Solid Tumor Oncology Division (156)
  6. Surgery (59)

More Groups

People
  1. Carol Aghajanian (85)
  2. William Tew (60)
  3. Paul Sabbatini (52)
  4. Martee Hensley (49)
  5. Alexia Iasonos (44)
  6. Roisin O'Cearbhaill (43)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (8)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Gynecologic Oncology (31)
  3. International Journal of Gynecological Cancer (14)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (9)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Elsevier Inc. (35)
  3. American Association for Cancer Research (15)
  4. Lippincott Williams & Wilkins (15)
  5. Oxford University Press (11)
  6. Springer (6)

More Publishers

Results (156)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer
    Journal Article

    Moore, K. N.; Martin, L. P.; O'Malley, D. M.; Matulonis, U. A.; Konner, J. A.; Vergote, I.; Ponte, J. F.; Birrer, M. J.
    Future Oncology (2018)

    Fulltext@MSK | Save
  • Mirvetuximab soravtansine (IMGN853), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in platinum-resistant epithelial ovarian cancer (EOC) patients (pts): Activity and safety analyses in phase I pooled expansion cohorts
    Meeting Abstract

    Moore, K. N.; Matulonis, U. A.; O'Malley, D. M.; Konner, J. A.; Martin, L. P.; Perez, R. P.; Bauer, T. M.; Gilbert, L.; Seward, S. M.; Oza, A. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013
    Journal Article

    Oseledchyk, A.; Leitao, M. M. Jr; Konner, J.; O'Cearbhaill, R. E.; Zamarin, D.; Sonoda, Y.; Gardner, G. J.; Roche, K. L.; Aghajanian, C. A.; Grisham, R. N.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase I expansion study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in patients with endometrial cancer
    Meeting Abstract

    Martin, L.; Konner, J.; O'Malley, D.; Bauer, T.; Matulonis, U.; Seward, S.; Oza, A.; Kirby, M.; Birrer, M.; Moore, K.
    International Journal of Gynecological Cancer (2017)

    Fulltext@MSK | Save
  • Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient
    Meeting Abstract

    Jiménez-Sánchez, A.; Veeraraghavan, H.; Li, Y.; Vargas, H. A.; Gill, M. B.; Park, K. J.; Zivanovic, O.; Konner, J.; Ricca, J.; Zamarin, D.; more...
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
    Journal Article

    Weigelt, B.; Comino-Méndez, I.; de Bruijn, I.; Tian, L.; Meisel, J. L.; Garcia-Murillas, I.; Fribbens, C.; Cutts, R.; Martelotto, L. G.; Ng, C. K. Y.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Genetic predisposition to bevacizumab-induced hypertension
    Journal Article

    Frey, M. K.; Dao, F.; Olvera, N.; Konner, J. A.; Dickler, M. N.; Levine, D. A.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save